Popped

Why Viking Therapeutics Stock Popped Nearly 4% Today

The Motley Fool

Numerous companies in the healthcare sector are feverishly busy developing obesity drugs, as these products have taken the medical world by storm. One of the more prominent developers, clinical-stage biotech Viking Therapeutics (VKTX +0.04%), saw its share price rise by almost 4% on Thursday on the back of encouraging research about a certain property of

Why Viking Therapeutics Stock Popped Nearly 4% Today Read More »